Brian L. Venables

Orally Active Fusion Inhibitor of Respiratory Syncytial Virus

Christopher Cianci, Kuo‐Long Yu, Keith D. Combrink et al. · Antimicrobial Agents and Chemotherapy · 2004 · 140 citations · Full text

Pharmacy, Infectious Diseases, Medicinal Chemistry +17

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Kuo‐Long Yu, Ny Sin, Rita L. Civiello et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 72 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Paul M. Scola, Alan Xiangdong Wang, Andrew C. Good et al. · Journal of Medicinal Chemistry · 2014 · 68 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage

Beata Nowicka-Sans, Tricia Protack, Zeyu Lin et al. · Antimicrobial Agents and Chemotherapy · 2016 · 65 citations · Full text

Life Sciences, Infectious Diseases, Medicinal Chemistry +17

Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral Activity

Alicia Regueiro‐Ren, Zheng Liu, Yan Chen et al. · ACS Medicinal Chemistry Letters · 2016 · 54 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16